Oncotarget

Vol 10, No 1

January 1, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 1 of Oncotarget features Figure 7, "KEGG pathways," by Tschumper, et al.

Table of Contents

Editorial

TIL therapy and anti-CTLA4: can they co-exist?

TIL therapy and anti-CTLA4: can they co-exist?

https://doi.org/10.18632/oncotarget.26509

Marie-Andrée Forget, Cara Haymaker, Rodabe N. Amaria,  and Chantale Bernatchez
1-2
PDF  |  How to cite  |  Order a Reprint

Multidimensional intratumour heterogeneity in neuroblastoma

Multidimensional intratumour heterogeneity in neuroblastoma

https://doi.org/10.18632/oncotarget.26524

Kristoffer von Stedingk, David Gisselsson,  and Daniel Bexell
3-5
PDF  |  How to cite  |  Order a Reprint

Role of acid sphingomyelinase-induced ceramide generation in response to radiation

Role of acid sphingomyelinase-induced ceramide generation in response to radiation

https://doi.org/10.18632/oncotarget.26526

Deepa Sharma,  and Gregory J. Czarnota
6-7
PDF  |  How to cite  |  Order a Reprint

Phase 3 LILAC study sets standard for clinical evaluation of oncology biosimilars

Phase 3 LILAC study sets standard for clinical evaluation of oncology biosimilars

https://doi.org/10.18632/oncotarget.26528

Hans-Christian Kolberg, Gunter von Minckwitz,  and Vladimir Hanes
8-9
PDF  |  How to cite  |  Order a Reprint

Combination of lenalidomide and vitamin D enhances MOR202-mediated cytotoxicity of macrophages: It takes three to tango

Combination of lenalidomide and vitamin D enhances MOR202-mediated cytotoxicity of macrophages: It takes three to tango

https://doi.org/10.18632/oncotarget.26531

Cindy Flamann, Leonhard Busch, Andreas Mackensen,  and Heiko Bruns
10-12
PDF  |  How to cite  |  Order a Reprint

Research Perspectives

Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)

Simplifying checkpoint inhibitor delivery through in vivo generation of synthetic DNA-encoded monoclonal antibodies (DMAbs)

https://doi.org/10.18632/oncotarget.26535

Alfredo Perales-Puchalt, Elizabeth K. Duperret, Kar Muthumani,  and David B. Weiner
13-16
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Research Papers

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate

https://doi.org/10.18632/oncotarget.26523

Leonidas Apostolidis, Cathleen Nientiedt, Eva Caroline Winkler, Anne Katrin Berger, Clemens Kratochwil, Annette Kaiser, Anne-Sophie Becker, Dirk Jäger, Markus Hohenfellner, Clemens Hüttenbrink, Sascha Pahernik, Florian A. Distler,  and Carsten Grüllich
17-29
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells

FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells

https://doi.org/10.18632/oncotarget.26530

Ming Zhao, Ming-Lei Zhuo, Xiaofeng Zheng, Xiaoping Su,  and Funda Meric-Bernstam
30-44
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells

Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells

https://doi.org/10.18632/oncotarget.26534

Esraah Alharris, Narendra P. Singh, Prakash S. Nagarkatti,  and Mitzi Nagarkatti
45-59
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia

Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia

https://doi.org/10.18632/oncotarget.26538

Renee C. Tschumper, Tait D. Shanafelt, Neil E. Kay,  and Diane F. Jelinek
60-75
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma

Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma

https://doi.org/10.18632/oncotarget.26539

Goro Kasuya, Hiroshi Tsuji, Takuma Nomiya, Hirokazu Makishima, Yasuo Haruyama, Gen Kobashi, Kazuhiko Hayashi, Daniel K. Ebner, Tokuhiko Omatsu, Riwa Kishimoto, Shigeo Yasuda, Tatsuo Igarashi, Mototsugu Oya, Koichiro Akakura, Hiroyoshi Suzuki, Tomohiko Ichikawa, Jun Shimazaki,  and Tadashi Kamada and the Working Group for Genitourinary Tumors
76-81
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC